First National Bank of South Miami’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-840
Closed -$34K 276
2022
Q4
$34K Hold
840
0.03% 206
2022
Q3
$34K Hold
840
0.03% 207
2022
Q2
$35K Hold
840
0.02% 218
2022
Q1
$38K Hold
840
0.02% 231
2021
Q4
$39K Hold
840
0.02% 235
2021
Q3
$40K Hold
840
0.03% 227
2021
Q2
$43K Hold
840
0.03% 219
2021
Q1
$42K Hold
840
0.03% 205
2020
Q4
$44K Hold
840
0.04% 193
2020
Q3
$37K Hold
840
0.04% 181
2020
Q2
$36K Hold
840
0.04% 177
2020
Q1
$30K Hold
840
0.04% 180
2019
Q4
$38K Hold
840
0.04% 176
2019
Q3
$30K Hold
840
0.03% 198
2019
Q2
$32K Hold
840
0.03% 200
2019
Q1
$35K Hold
840
0.03% 197
2018
Q4
$34K Buy
+840
New +$35.8K 0.03% 200

Other funds holding XPH

First National Bank of South Miami's XPH Position: Q1 2023 in Review

First National Bank of South Miami sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2023, closing a stake of 840 shares — an estimated $34K sold.

First National Bank of South Miami first reported a position in XPH in Q4 2018 and held it in 17 quarters. The position peaked at $44K in Q4 2020. 61 funds tracked by Wall St. Rank hold XPH as of Q1 2023.

  • First National Bank of South Miami reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
  • First National Bank of South Miami sold 840 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2023, an estimated $34K.
  • First National Bank of South Miami first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2018 and held it in 17 quarters.
  • First National Bank of South Miami's State Street SPDR S&P Pharmaceuticals ETF position peaked at $44K in Q4 2020.
  • 61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2023.

Based on First National Bank of South Miami's 13F filing for Q1 2023, filed 17 Apr 2023.